Novelion Therapeutics Inc. (NVLN) Gained 8.85% or 0.4 To Price $4.92 On Tuesday


Novelion Therapeutics Inc. (NVLN) gained 8.85% or 0.4 to $4.92. It is around 51577 shares traded, which is 73.9% compare to the average total volume 69796. The market cap of NVLN is $91.31 million. The year to date change is 35.74%. The 52 week price range is from $3.08 to $12.12. Price of NVLN have changed -8.69% during last week. It have changed 14.43% over last month, -8.87% over last 3 months, -50.98% over last 6 months and -55.34% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NVLN is 3.92. It is -20.33% below current price. The 200-day Moving Averages for NVLN is 6.97. It is 41.67% above current price. The 52-week High is 12.12. It is 146.34% from the current price. The 52-week Low is 3.08. It is -37.40% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of NVLN is 27.4 on 2018-01-12. Short % to float is 10.86%. There are some statistics of NVLN. It is has market cap $91.31 million. The share outstanding is 18.56 million. The average volume is 69796. The revenue is 113.10M. The gross profit is 46.91M. The percent of top 15 Institution holding is 80.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NVLN is -216.13%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NVLN is -50.09%.


Tags:

Share this post